WebDisclosure WebDisclosure
Basculer en Français
9904 Companies
199549 Keywords
130408 Articles
106052 Press releases
Headlines Articles Press releases IOmx Therapeutics AG Remove
  1. Home
  2. Companies
  3. IOmx Therapeutics AG
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 06/27/2024 at 10:05, 1 year 7 months ago

    IOmx Therapeutics nomme Florian Schmid au poste de directeur financier

    Biopharmaceutique Direction Directeur Financier Florian Schmid IOmx Thérapeutique
  • PRESS RELEASE

    published on 06/27/2024 at 10:00, 1 year 7 months ago

    iOmx Therapeutics Appoints Florian Schmid as New Chief Financial Officer

    iOmx Therapeutics appoints Florian Schmid as new Chief Financial Officer, succeeding Marcus Irsfeld. Schmid brings 20+ years of financial leadership experience in biopharma. Company aims to advance immuno-oncology drug candidates
    Chief Financial Officer Biopharmaceutical Immuno-oncology IOmx Therapeutics Florian Schmid
    Logo of IOmx Therapeutics AG
  • PRESS RELEASE

    published on 11/01/2023 at 10:00, 2 years 3 months ago

    iOmx Therapeutics attends upcoming scientific and industry conferences

    Logo of IOmx Therapeutics AG
  • PRESS RELEASE

    published on 09/05/2023 at 08:30, 2 years 5 months ago

    iOmx Therapeutics appoints Dr. Nils Peter Debus as Chief Business Officer

    Logo of IOmx Therapeutics AG
  • PRESS RELEASE

    published on 04/04/2023 at 10:00, 2 years 10 months ago

    iOmx Therapeutics Announces Dosing of First Patient with SIK Inhibitor OMX-0407 in Phase I Clinical Trial

    Logo of IOmx Therapeutics AG
  • PRESS RELEASE

    published on 02/23/2023 at 10:00, 2 years 11 months ago

    iOmx Therapeutics appoints Dr. Christine Rothe as new Chief Development Officer

    Logo of IOmx Therapeutics AG
Previous page
1 2
Accesswire
  • Published on 02/20/2026 at 21:40, 16 minutes ago

    IBC Advanced Alloys Announces Closing of Initial US$1,250,000 Funding by The Lind Partners

  • Published on 02/20/2026 at 20:15, 1 hour 41 minutes ago

    Lithium South Announces Results of its Annual and Special Meeting of Securityholders

  • Published on 02/20/2026 at 20:15, 1 hour 41 minutes ago

    Verdera Energy Announces Closing of Qualifying Transaction

  • Published on 02/20/2026 at 18:30, 3 hours 26 minutes ago

    Sparta Updates Delay in Filing Annual Financial Statements

  • Published on 02/20/2026 at 15:45, 6 hours 11 minutes ago

    Revolve Announces Closing of Initial US$10 Million Advance on Strategic Financing With Callaway

View all ACCESSWIRE
EQS Group
  • Published on 02/20/2026 at 18:36, 3 hours 19 minutes ago

    EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share

  • Published on 02/20/2026 at 18:31, 3 hours 25 minutes ago

    Fuller, Smith & Turner PLC: Transaction in own shares

  • Published on 02/20/2026 at 18:23, 3 hours 33 minutes ago

    POS-Transaction in Own Shares

  • Published on 02/20/2026 at 18:00, 3 hours 56 minutes ago

    Leclanché conclut un accord de financement d’un montant de CHF 16,7 millions pour soutenir ses opérations à court terme

  • Published on 02/20/2026 at 18:00, 3 hours 56 minutes ago

    Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations

View all EQS
Les Echos
  • Published on 02/20/2026 at 19:29, 2 hours 27 minutes ago

    SFPI GROUP: Liquidity agreement report S2 2025

  • Published on 02/20/2026 at 19:29, 2 hours 27 minutes ago

    SFPI GROUP: bilan du contrat de liquidité S2 S025

  • Published on 02/20/2026 at 18:00, 3 hours 56 minutes ago

    TERACT - Termination of liquidity agreement

  • Published on 02/20/2026 at 18:00, 3 hours 56 minutes ago

    TERACT - Résiliation du contrat de liquidité

  • Published on 02/20/2026 at 17:35, 4 hours 21 minutes ago

    CHIFFRE D'AFFAIRES 2025

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy